In sarcoidosis trials, time also matters.

Autor: Jeny F; AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, France florence.jeny@aphp.fr.; INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, France., Nunes H; AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, France.; INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, France., Valeyre D; INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, France.; Groupe hospitalier Paris Saint Joseph, Pulmonology Department, Paris, France.
Jazyk: angličtina
Zdroj: The European respiratory journal [Eur Respir J] 2024 Jan 18; Vol. 63 (1). Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2024).
DOI: 10.1183/13993003.01629-2023
Abstrakt: Competing Interests: Conflict of interest: F. Jeny reports lecture honoraria from Boehringer Ingelheim, travel support from Oxyvie, and payment from Wickenstones for an online expert questionnaire, outside the submitted work. H. Nunes reports grants from Boehringer Ingelheim, Kinevant and Atyr, and advisory board participation with Boehringer Ingelheim and Janssen, outside the submitted work. D. Valeyre reports lecture honoraria from Boehringer Ingelheim and AstraZeneca, outside the submitted work.
Databáze: MEDLINE